Author:
Xiang Yongguo,Wang Xiaoqin,Cao Xiaochuan,Wei Fang,Chen Yu,Ran Jianchuan,Long Zhengqin,Tan Qunwu,Lai Zhenying,Liu Li,Zhao Desheng,Xiong Liang,Tang Bin,Wan Wenjuan,Hu Ke
Abstract
Abstract
Objective
To determine the efficacy of cataract surgeries in blindness prevention programs in Chongqing.
Methods
During February–December 2019, we prospectively enrolled 487 patients (592 eyes) undergoing cataract surgery during blindness prevention programs in 6 Chongqing district/county hospitals (experimental group) and 481 patients (609 eyes) undergoing cataract surgery in the First Affiliated Hospital of Chongqing Medical University (controls). Uncorrected visual acuity (UCVA), refractive status, best corrected visual acuity (BCVA), slit lamp examination, and visual function/quality of life (VF-QOL) questionnaire scores were evaluated preoperatively, and at 1 and 6 months postoperatively.
Results
In the experimental group, UCVA, BCVA, and VF-QOL scores at 1 and 6 months were better than the preoperative values (P < 0.05), but lower than the control-group values (P < 0.05). Rates of good UCVA and BCVA outcomes (≤ 0.5 logMAR) in the experimental group were 76.2% and 87.6%, respectively, at 1 month and 68.9% and 83.1%, respectively, at 6 months. Most eyes in the experimental (82.1%) and control (89.5%) groups had refractive errors within ± 1 D at 1 month. At 6 months, posterior capsule opacification (PCO) was more common in the experimental group (20.9% vs. 15.0%, P < 0.05). At 6 months, the main causes of visual impairment (UCVA > 0.5 logMAR) in the experimental group were uncorrected refractive errors (33.0%), PCO (29.5%), and fundus diseases (33.9%).
Conclusion
Cataract surgeries in blindness prevention programs in Chongqing significantly improved visual acuity, VF, and QOL, but underperformed compared to surgeries in the tertiary teaching hospital.
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference53 articles.
1. GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to Sight: an analysis for the global burden of Disease Study. Lancet Glob Health. 2021 Feb;9(2):e144–60.
2. Xu TL, Wang BS,Liu H, et al. Prevalence and causes of vision loss in China from 1990 to 2019: findings from the global burden of Disease Study 2019.[J]. Lancet Public Health. 2020;5:e682–91.
3. Zhao JL, Xu X, Ellwein LB, et al. Causes of visual impairment and blindness in the 2006 and 2014 Nine-Province surveys in Rural China[. J] Am J Ophthalmol. 2019;197:80–7.
4. Song P, Wang H,Theodoratou E, et al. The national and subnational prevalence of cataract and cataract blindness in China: a systematic review and meta-analysis[. J] J Glob Health. 2018;8:010804.
5. He MG, Wang W, Zhao. JL,[Prevention of blindness and ophthalmic epidemiology in China over the past 70 years].[J].Zhonghua Yan Ke Za Zhi, 2020, 56: 561–6.